Floyd Hassenrück

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Diffuse Large B Cell Lymphoma

Extracellular Matrix

Chronic Lymphocytic Leukemia

Oxidative Stress

Top Venues

BioMed research international

British journal of pharmacology

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Floyd Hassenrück, Maria Farina-Morillas, Lars Neumann, Francesco Landini, Stuart James Blakemore, Mina Rabipour, Juan Raúl Álvarez-Idaboy, Christian P Pallasch, Michael Hallek, Rocio Rebollido-Rios, Günter Krause
Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ. Communications biology 6 (1) (2023)
Salem Alawbathani, Mehreen Batool, Jan Fleckhaus, Sarkawt Hamad, Floyd Hassenrück, Yanhong Hou, Xia Li, Jon Salmanton-García, Sami Ullah, Frederique Wieters, Martin Christian Michel
A teaching tool about the fickle p value and other statistical principles based on real-life data. Naunyn-Schmiedeberg's archives of pharmacology 394 (6) (2021)
Günter Krause, Floyd Hassenrück, Michael Hallek
Cell line-based assessment of BTK inhibitors. British journal of pharmacology 177 (9) (2020)
Günter Krause, Floyd Hassenrück, Michael Hallek
Relevant Cytokines in the B Cell Lymphoma Micro-Environment. Cancers 12 (9) (2020)
Floyd Hassenrück, Eva Knödgen, Elisa Göckeritz, Safi Hasan Midda, Verena Vondey, Lars Neumann, Sylvia Herter, Christian Klein, Michael Hallek, Günter Krause
Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors. BioMed research international 2018 (2018)